» Authors » Stefan Hadzic

Stefan Hadzic

Explore the profile of Stefan Hadzic including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 201
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lingampally A, Truchi M, Shi X, Zhou Y, Vasquez-Pacheco E, Panagiotidis G, et al.
Aging Cell . 2025 Feb; :e14503. PMID: 39945330
Idiopathic pulmonary fibrosis (IPF) is an age-associated disease characterized by the irreversible accumulation of excessive extracellular matrix components by activated myofibroblasts (aMYFs). Following bleomycin administration in young mice, fibrosis formation...
2.
Khadim A, Kiliaris G, Vazquez-Armendariz A, Procida-Kowalski T, Glaser D, Bartkuhn M, et al.
Cell Rep . 2025 Feb; 44(2):115248. PMID: 39903667
Alveolar regeneration requires the coordinated engagement of epithelial stem cells and mesenchymal niche cells to restore the intricate alveolar architecture of the lung. The current paradigm is that certain aspects...
3.
Lingampally A, Truchi M, Mauduit O, Delcroix V, Vasquez-Pacheco E, Gautier-Isola M, et al.
Eur Respir J . 2024 Oct; 65(2). PMID: 39401861
Background: Fibrosis is often associated with aberrant repair mechanisms that ultimately lead to organ failure. In the lung, idiopathic pulmonary fibrosis (IPF) is a fatal form of interstitial lung disease...
4.
Dabral S, Noh M, Werner F, Krebes L, Volker K, Maier C, et al.
Commun Biol . 2024 Jun; 7(1):693. PMID: 38844781
Pericyte dysfunction, with excessive migration, hyperproliferation, and differentiation into smooth muscle-like cells contributes to vascular remodeling in Pulmonary Arterial Hypertension (PAH). Augmented expression and action of growth factors trigger these...
5.
Chu X, Kheirollahi V, Lingampally A, Chelladurai P, Valasarajan C, Vazquez-Armendariz A, et al.
Circ Res . 2024 Apr; 134(11):e133-e149. PMID: 38639105
Background: The precise origin of newly formed ACTA2+ (alpha smooth muscle actin-positive) cells appearing in nonmuscularized vessels in the context of pulmonary hypertension is still debatable although it is believed...
6.
Gredic M, Hadzic S
J Pers Med . 2023 Oct; 13(10). PMID: 37888057
Pulmonary hypertension (PH) is a progressive and life-threatening disease characterized by increased pulmonary arterial pressure, which leads to right heart hypertrophy and eventually right heart failure [...].
7.
Hadzic S, Wu C, Gredic M, Pak O, Loku E, Kraut S, et al.
Eur Respir J . 2023 Oct; 62(5). PMID: 37884305
Background: COPD is an incurable disease and a leading cause of death worldwide. In mice, fibroblast growth factor (FGF)10 is essential for lung morphogenesis, and in humans, polymorphisms in the...
8.
Castro C, Nardiello C, Hadzic S, Kojonazarov B, Kraut S, Gierhardt M, et al.
Aging Dis . 2023 Aug; 15(2):911-926. PMID: 37548932
The mitochondrial adaptor protein p66Shc has been suggested to control life span in mice via the release of hydrogen peroxide. However, the role of p66Shc in lung aging remains unsolved....
9.
Wygrecka M, Hadzic S, Potaczek D, Alexopoulos I, El Agha E, Schaefer L
Pol Arch Intern Med . 2023 Jun; 133(7-8). PMID: 37387676
Idiopathic pulmonary fibrosis (IPF) is a progressive and life‑threatening interstitial lung disease of familial or sporadic onset. The incidence and prevalence of IPF range from 0.09 to 1.3 and from...
10.
Wu C, Cilic A, Pak O, Dartsch R, Wilhelm J, Wujak M, et al.
Am J Respir Crit Care Med . 2023 May; 207(12):1576-1590. PMID: 37219322
Tobacco smoking and air pollution are primary causes of chronic obstructive pulmonary disease (COPD). However, only a minority of smokers develop COPD. The mechanisms underlying the defense against nitrosative/oxidative stress...